Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704291 | SCV000527447 | likely benign | not provided | 2021-06-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000534631 | SCV000655423 | benign | Developmental and epileptic encephalopathy, 26 | 2024-12-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704291 | SCV004154686 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | KCNB1: BP5, BS1:Supporting |
Ambry Genetics | RCV004022402 | SCV004889002 | likely benign | Inborn genetic diseases | 2023-10-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004533052 | SCV004715887 | likely benign | KCNB1-related disorder | 2023-11-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |